GSE114298 Targeting EZH2 reprograms intratumoral regulatory T cells to enhance cancer immunity

This study reveals a novel strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.

http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE114298

Source: GEO: Gene Expression Omnibus - June 1, 2018 Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Mus musculus Source Type: research